3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Carboplatin
40
Paclitaxel
30
Bevacizumab
16
Gemcitabine
14
Cyclophosphamide
14
liposomal doxorubicin
13
Taxes
12
Topotecan
11
Cisplatin
11
Docetaxel
7
veliparib
6
pembrolizumab
6
olaparib
6
Doxorubicin
6
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
sargramostim
4
fludarabine
4
aldesleukin
4
Specimen Handling
4
Oxaliplatin
4
Leucovorin
4
Immunoglobulin G
4
Filgrastim
4
Drug Therapy
4
Disulfides
4
Biopsy
4
talazoparib
3
mirvetuximab soravtansine
3
Radiotherapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Fallopian Tube Neoplasms
×
NUC-1031
×
Clear all
NCT02303912
2021-05-18
ProGem2
Imperial College Healthcare NHS Trust
Phase 1
Completed
25 enrolled